VASCULAR COMPLICATIONS OF DIABETES - PART 1 ppt
VASCULAR COMPLICATIONS OF DIABETES - PART 1 ppt
... bibliographical references and index. ISBN -1 3 : 97 8 -1 -4 05 1- 2 78 5 -1 (alk. paper) ISBN -1 0 : 1- 4 05 1- 2 78 5-6 (alk. paper) 1. Diabetic angiopathies. [DNLM: 1. Diabetes Complications. 2. Diabetic Retinopathy ... 4. Vascular Diseases etiology. WK 835 V3305 2005] I. Donnelly, Richard, 19 6 0- II. Horton, Edward S. RC700.D5V375 2005 616 .1& apos;3 dc22 2005008488...
Ngày tải lên: 10/08/2014, 18:21
VASCULAR COMPLICATIONS OF DIABETES - PART 7 pptx
... Ophthalmology 19 84; 91: 14 64 14 74. Relationship of Diabetic Retinopathy with Macular Oedema* and Duration of Diabetes (Wisconsin, HAS -1 , 19 8 0-8 2) Younger onset Older onset Duration 10 + years Duration 0 14 ... DISORDERS 15 2 Fig. 17 .1 Frequency of macular oedema by duration of diabetes in years for insulin- taking early onset persons. Ophthalmology 19 84; 91:...
Ngày tải lên: 10/08/2014, 18:21
VASCULAR COMPLICATIONS OF DIABETES - PART 2 pot
... R, 19 75. BMJ 19 86; 293: 11 19 11 20). Serum creatinine (μmol/l) 400 600 800 10 00 12 00 14 00 16 00 200 0 0204060 GFR ( 51 Cr EDTA) 80 10 0 12 0 SECTION I • MICRO- AND MACROVASCULAR COMPLICATIONS OF DIABETES 34 FURTHER ... cohort study found a history of MI in 16 .5% of males and 9.7% of females at the time of diagnosis of diabetes. During a 10 -year follow-up...
Ngày tải lên: 10/08/2014, 18:21
VASCULAR COMPLICATIONS OF DIABETES - PART 3 potx
... mortality Kaplan-Meier rates 0.08 0 .10 0 .12 0.06 0.02 0.04 0.00 0 500 Days of follow-up Ramipril Placebo RRR = 37% (2 1- 5 1) P=0.00 01 1000 15 00 2000 CHAPTER 6 ERECTILE DYSFUNCTION Adrian R. Scott MD, FRCP 51 INTRODUCTION Diabetes ... over 10 years 10 0 patients over 10 years median HbA1 C 7% median HbA1 C 7.9% Patients with at least one end-point No. of patients (%)...
Ngày tải lên: 10/08/2014, 18:21
VASCULAR COMPLICATIONS OF DIABETES - PART 4 pot
... 0.3 0.2 0 .1 0 0.5 0.4 3 11 3 10 9 Baseline 11 4 11 1 n at risk: Placebo Captopril 6 10 8 10 4 9 98 96 12 91 90 15 86 89 21 69 77 18 78 85 24 40 41 Proportion with event Month Fig. 7.6 Effect of glycaemic control ... infarction Stroke Cardiovascular death 0 .12 Kaplan-M 0 08 0.04 0 0 500 10 00 200 015 00 0.08 0.06 Kaplan-M 0 04 0.02 0 0 500 10 00 200 015 00 0 .12 0.0...
Ngày tải lên: 10/08/2014, 18:21
VASCULAR COMPLICATIONS OF DIABETES - PART 5 ppsx
... studies Placebo 30 μg/g 10 0 μg/g Study 1 (II -1 1 8) 25 48 Steed et al. J Vasc Surg 19 95; 21: 71 78. Study 2 (III-382) 35 36 50 Wieman et al. Diabetes Care 19 98; 21: 822–827. Study 3 (III -1 7 2) 36 44 D’Hemercourt ... 11 2: 19 1 19 4. 11 1 SECTION II • DIABETIC NEUROPATHIES 11 0 type 1 diabetes but not in type 2 diabetes. Thus calcaneal bone density does not differ in men...
Ngày tải lên: 10/08/2014, 18:21
VASCULAR COMPLICATIONS OF DIABETES - PART 6 doc
... Phenytoin Wilton 19 74 Carbamazepine Rull 19 69 Carbamazepine 2. 31 (1. 87, 2.85) 2.76 (1. 50, 5.25) 3.43 (1. 66, 7.93) 1. 84 (1. 30, 2.67) 2.80 (1. 66, 5.05) 2.67 (1. 48, 5.08) 1. 87 (1. 35, 2.84) CHAPTER 15 • EPIDEMIOLOGY ... 4- year and 10 -year period is 59% and 90%, respectively. • The incidence of proliferative retinopathy over a 4-year and 10 -year peri- od is 11 % and 3...
Ngày tải lên: 10/08/2014, 18:21
VASCULAR COMPLICATIONS OF DIABETES - PART 8 doc
... vivo factors such as the catabolism of ketone bodies and threonine. 1. 3 1. 1 1. 0 0 1. 00 3 1. 21 2 1. 13 1 1.07 0 1. 00 15 1. 16 10 1. 10 20 1. 21 5 1. 05 1. 2 2-hour-PG mmol/L SBP mm/Hg Relative risk Table ... risk 1. 00 2.74 2.77 5.20 10 . 91 <0.0 01 Non-cardiovascular disease (n=75) Age adjusted rate /10 0 1. 15 (13 ) 1. 06 (16 ) 2 .19 (39) 1. 81 (2) 1. 8...
Ngày tải lên: 10/08/2014, 18:21
VASCULAR COMPLICATIONS OF DIABETES - PART 9 doc
... (% of control) 15 0 14 0 13 0 12 0 11 0 10 0 0 0 10 0 11 0 12 0 13 0 14 0 15 0 16 0 17 0 0 010 -1 1 10 -1 0 10 -9 TPA (M) 10 -8 10 -7 10 -6 n.s 10 20 Glucose (mM) Mannose 30 40 520 mmol Table 21. 1 Diabetes- related ... Medicine 19 95; 12 : 14 9 15 5. Survival probability 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 None Light Heavy Ye...
Ngày tải lên: 10/08/2014, 18:21
VASCULAR COMPLICATIONS OF DIABETES - PART 10 potx
... dependency 51, 52 aldose reductase 76, 85, 86, 12 4, 17 1, 18 7, 18 8, 18 9 aldose reductase inhibitors 85, 11 3 14 , 11 3, 12 4 alkaline phosphatase 32, 11 0 allodynia 80, 91, 11 6 alpha-lipoic acid 11 4, 12 4 alpha-oxoaldehydes ... 23 PKC-β 2 5.9 19 PKC-γ 300 11 0 PKC-δ 250 28 PKC-ε 600 18 PKC-ζ > ;10 5 > ;1. 5 × 10 3 PKC-η 52 5 Cyclic AMP kinase > ;10 5 10 0 Ca...
Ngày tải lên: 10/08/2014, 18:21